Conference Coverage
about 4 hours ago
Pharmacies Should Keep Pace With Changing Technology | NCPA 2025Trending on Drug Topics
Eli Lilly, Walmart Announce Expansion of Direct-to Consumer Access for Tirzepatide
White House Announces Action to Increase Competition, Decrease Cost of Biosimilar Development
Pass-Through Rebate Law Uncovering New PBM Tactics, Entities | NCPA 2025
FDA Approves Mirikizumab as Once Monthly Injection for Moderately to Severely Active Ulcerative Colitis
Community Pharmacies Need to Better Prioritize Whole-Person Health Care | NCPA 2025
Latest Content
Shorts










Podcasts

American Pharmacists Month: How Community Pharmacy Innovation Relies on Expansion, Collaboration
With the constant financial hurdles businesses must maneuver, the community pharmacy industry has lately struggled with finding new ways to innovate within their practices.

Amplifying Technicians: Grace Fick
In this episode, host Taylor Watterson, PharmD, PhD, welcomes Grace Fick, PharmD candidate and pharmacy research assistant at the University of Illinois Chicago.

American Pharmacists Month: Pharmacy Education Adapting to Evolving Pharmacist Profession
Exploring the evolution of pharmacy education throughout his professional career, Brad Phillips, PharmD, BCACP, joined Over the Counter to discuss trends in pharmacy students’ career paths.

Scripted for Her: Intimate Partner Violence Awareness
In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, chats with Marie Barnard, PhD, about the ways in which pharmacists can support patients experiencing intimate partner violence.

American Pharmacists Month: Technology Enables Better Patient Care, Pharmacy Growth
In today’s world, the exponential use of technology is gradually becoming commonplace, and pharmacy businesses are expected to keep up with the growing digital landscape.

Dispensing Leadership: Changing Yourself to Change the World
This episode explores a dynamic pharmacy profession and how self-inflection can lead to pharmacists achieving their passions and improving care in their communities.

Scripted for Her: Maternal Immunizations
In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, chats with Hannah Fish, PharmD, CPHQ, about the NCPA’s maternal immunizations tool kit and pharmacist support for mothers.

The Pharmacist’s Ability to Overcome Barriers, Expand Contraceptive Services
As contraceptive care services remain fragmented across many US states, pharmacists are seemingly rising as key touch points for women’s health management and various types of reproductive care.

The Emerging Technology, Data Introducing Accountability in the PBM Industry
With disruptive PBMs rising in the marketplace amid constant calls for lowering drug prices, companies such as WriteWise are positioned to revolutionize the way patients access their pharmacy benefits.

Amplifying Technicians: Shane Desselle, RPh, PhD, FAPhA
In this episode, host Taylor Watterson, PharmD, PhD, welcomes Shane Desselle, RPh, PhD, FAPhA, professor of Pharmacy Practice and Social Pharmacy at Touro University California.
Total Pharmacy
Continuing Medical Education
All News

The approval includes a single and once monthly maintenance injection compared with 2 100 mg/1 mL injections.

Alyssa Mack, PharmD, discusses events like the pandemic and new pharmacy laws that have allowed for an expansion of pharmacists’ scope of practice.

Andrew M. Peterson, PharmD, PhD, FCPP, discusses how behavioral health services in community pharmacy help patients receive care impacting all factors of their health and not just medications.

Pharmacists redefine their roles as vital health care providers, offering comprehensive patient care and community health advocacy beyond medication dispensing.

Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, shareholders with Buchanan Ingersoll & Rooney, discuss Utah’s pharmacy benefit manager pass-through rebate law.

Alyssa Mack, PharmD, pharmacist at Gibbs Pharmacy and Compounding Center in Tennessee, discusses her role in expanding clinical services within her practice.

Tara Pfund, PharmD, chief strategy officer with Cascadia Pharmacy Group, discusses the importance of automation and its emerging role in pharmacy practices.

Pneumococcal conjugate vaccines significantly reduce pneumonia incidence in children, but safety concerns warrant further investigation in future studies.

Georgia Travlos, PharmD, discusses changes in flu and respiratory syncytial virus immunizations and coadministration best practices.

A study reveals that lower baseline BMI and early weight loss with liraglutide enhance significant weight loss outcomes in type 2 diabetes patients.

Patients and physicians favor at-home remdesivir treatment for COVID-19, highlighting satisfaction and confidence in telehealth and nursing support.

Before delinking, pharmacy benefit managers were able to tie their fees to significantly high-priced medications, in turn receiving large percentages of compensation rather than flat, fixed fees.

PCV21 improved all outcomes for those aged 19 to 64 years, including invasive pneumococcal disease, post-meningitis sequelae, and nonbacteremic pneumococcal pneumonia.

With the constant financial hurdles businesses must maneuver, the community pharmacy industry has lately struggled with finding new ways to innovate within their practices.

Research reveals no significant disparities in cardiovascular disease incidence linked to mental disorders after the COVID-19 pandemic.

Jennifer Griffin, PharmD, MS, clinical pharmacist at Harps Food Stores, Inc, discusses the basis of having reimbursement pathways in community pharmacy that consistently generate revenue.

Pharmacies evolve with flexible designs and enhanced roles for pharmacists, improving patient care and privacy in community health settings.

Investigators explore how long COVID impacts trust in vaccines, revealing diverse patient experiences and the need for better communication in public health.

Steve Moore, PharmD, owner of Condo Pharmacy in Plattsburgh, New York, discusses how well-developed partnerships with various stakeholders in the drug supply chain can improve patient care.

Andrew M. Peterson, PharmD, PhD, FCPP, discusses the growing opportunities for pharmacies to assist in managing patients’ behavioral health.

Tara Pfund, PharmD, chief strategy officer with Cascadia Pharmacy Group, discusses her experience developing new technology workflows that drive pharmacy efficiency.

Pharmacists can help patients navigate the vast array of OTC options for effective pain relief, fever reduction, and targeted symptom management.

Steve Moore, PharmD, owner of Condo Pharmacy in Plattsburgh, New York, discusses his pharmacy’s ability to provide clinical services and the common roadblocks his team encounters.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Grace Fick, PharmD candidate and pharmacy research assistant at the University of Illinois Chicago.

Jennifer Griffin, PharmD, MS, clinical pharmacist at Harps Food Stores, Inc, discusses billing for clinical services and how pharmacies need to prioritize credentialing.

Tezspire gains FDA approval as the first biologic for chronic rhinosinusitis with nasal polyps, offering improved patient outcomes.

The approval expands options for protecting infants from respiratory syncytial virus, which remains a leading cause of pediatric hospitalization.

National Check Your Meds Day, observed on October 21, is an important annual reminder of the value of these pharmacist-led interventions.

Pharmacists enhance patient care through automation, blood pressure monitoring, and community health services, improving accessibility and reducing burnout.

Pharmacy technicians seek recognition that values their contributions, emphasizing personal, professional, and practical appreciation to enhance morale and engagement.

Andrew M. Peterson, PharmD, PhD, FCPP, discusses social determinants of health, their impact on patients, and why pharmacists struggle to address them.

Emlah Tubuo, PharmD, MS, owner of Powell Pharmacy and founder of Emlah Consulting LLC, discusses the overall importance of supplement sales in community pharmacies.

FDA approves oral semaglutide for reducing cardiovascular risks in high-risk type 2 diabetes patients, enhancing treatment options and outcomes.




































































































































































